Header Logo

Connection

Calvin Ho to Eosinophils

This is a "connection" page, showing publications Calvin Ho has written about Eosinophils.
Connection Strength

0.282
  1. Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis. N Engl J Med. 2024 Jun 27; 390(24):2252-2263.
    View in: PubMed
    Score: 0.226
  2. Benralizumab does not elicit therapeutic effect in patients?with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial. Br J Dermatol. 2024 Jul 16; 191(2):187-199.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.